FDA approves flurpiridaz F-18 for diagnosing coronary artery disease Dr. Prem Aggarwal4 Oct 2024 9:15 AM ISTThe U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography...
Gefarnate Enhances Lipid Control in Statin-Treated CAD Patients with High Triglycerides, Study Finds Dr. Prem Aggarwal1 Oct 2024 9:00 AM ISTChina: In a randomized controlled trial, researchers have uncovered significant lipid-lowering benefits of gefarnate when added to statin therapy in...
Stent implantation preferred strategy for previously untreated non-complex coronary artery disease, States study Dr. Kamal Kant Kohli25 Sept 2024 8:45 PM ISTNovel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a...
Sex-Specific Differences Observed in Lipoprotein(a) Levels to Predict Coronary Artery Disease in new study Jacinthlyn Sylvia25 Sept 2024 7:00 AM ISTA recent study from the Koc University Hospital revealed crucial insights into the relationship between lipoprotein(a) [Lp(a)] levels and the risk of...
NOTION-3 Trial: PCI Reduces Major Adverse Events in TAVI Patients with Coronary Artery Disease Medha Baranwal14 Sept 2024 9:00 AM ISTDenmark: NOTION-3 randomized trial has highlighted the advantages of percutaneous coronary intervention (PCI) for patients undergoing transcatheter...
Optical coherence tomography outperforms conventional angiography for stent guidance in complex cases, reports research Dr. Kamal Kant Kohli11 Sept 2024 6:00 AM ISTUsing optimal coherence tomography (OCT) to guide stent implantation during percutaneous coronary intervention (PCI) in patients with complex coronary...
AI for heart scans may benefit decision making for less-experienced clinicians, suggests PROTEUS Trial Dr. Kamal Kant Kohli11 Sept 2024 5:00 AM ISTA large randomised trial showed no significant differences to demonstrate that using artificial intelligence (AI) to aid clinical decision-making in...
Novel bioadaptor effective and safe treatment option for CAD in challenging patient population, claims study Dr. Kamal Kant Kohli10 Sept 2024 9:30 AM ISTUndergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as a contemporary...
Diagnostic tools and ways to prevent major adverse events and enhance QoL expanded in New Chronic Coronary Syndrome Guidelines Dr. Kamal Kant Kohli1 Sept 2024 8:30 PM ISTThe 2024 ESC Guidelines on the management of chronic coronary syndromes (CCS) include a focus on both larger and smaller blood vessels of the heart;...
High-Intensity Statin Therapy Shows No Diabetes Difference for CAD Patients, LDL-C Impacts Outcome: LODESTAR Trial Analysis Medha Baranwal23 Aug 2024 8:15 AM ISTKorea: In a recent post-hoc analysis of the LODESTAR randomized clinical trial, researchers found that high-intensity statin therapy for patients with...
Predicting PCI Benefits in cath lab: Study Validates Symptom Verification with Ischemic Stimulus Medha Baranwal24 July 2024 9:30 AM ISTUK: ORBITA-STAR, an n-of-1 study, showed that verifying patient symptoms with an ischemic stimulus on the cath lab table can help predict which stable...
Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals Dr. Prem Aggarwal4 July 2024 12:22 PM ISTAtherosclerotic cardiovascular disease (ASCVD) among young adults is a major public health challenge with a global prevalence of 7% to 30%. (1) Due to...
